Table 1 Demographics and pharmacologic treatment in the JIA-cohort and references

Female (n (%))

433 (67.7)

2165 (67.7)

Age at JIA-diagnosis and/or cohort entry,

yrs (median (IQR))

8.7 (3.7—12.7) n 633

8.7 (3.7—12.7)

ANA positive, early onset (n (%))

192 (30.0)

NA

 < 6 years at diagnosis (n (%))

255 (39.8)

1275 (39.8)

ANA positive (n (%))

326 (50.9)

NA

Methotrexate (n (%))

270 (42.2)

NA

csDMARDs (n (%))

344 (53.8)

NA

bDMARDs (n (%))

119 (18.6)

NA

Any DMARD (n (%))

348 (54.4)

NA

Depression (n (%))

93 (14.5)

474 (14.8)

Anxiety (n (%))

111 (17.3)

557 (17.4)